<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="species">human</item><item key="factors"><item><item key="GSM1305909"><item key="CELL STATUS">CD40-activated</item><item key="DONOR ID">BC4885</item></item></item><item><item key="GSM1305908"><item key="CELL STATUS">Resting</item><item key="DONOR ID">BC4885</item></item></item><item><item key="GSM1305907"><item key="CELL STATUS">CD40-activated</item><item key="DONOR ID">BC4884</item></item></item><item><item key="GSM1305906"><item key="CELL STATUS">Resting</item><item key="DONOR ID">BC4884</item></item></item><item><item key="GSM1305905"><item key="CELL STATUS">CD40-activated</item><item key="DONOR ID">BC4870</item></item></item><item><item key="GSM1305904"><item key="CELL STATUS">Resting</item><item key="DONOR ID">BC4870</item></item></item><item><item key="GSM1305903"><item key="CELL STATUS">CD40-activated</item><item key="DONOR ID">BC4869</item></item></item><item><item key="GSM1305902"><item key="CELL STATUS">Resting</item><item key="DONOR ID">BC4869</item></item></item></item><item key="id">1204</item><item key="ownerprofile_id">arrayexpress_sid</item><item key="platform">3</item><item key="summary_wrapped">Antibody-independent effector functions of B cells, such as antigen presentation and cytokine production, have been shown to play an...</item><item key="geo_gse_id">E-GEOD-54017</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">2</item><item key="sample_count">8</item><item key="tags"><item>cell</item><item>cytokine</item><item>disease</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">cd40-activation-of-human-b-cells</item><item key="geo_id_plat">E-GEOD-54017_A-AFFY-33</item><item key="name">CD40-activation of human B cells</item><item key="created">Jun.18, 2014</item><item key="summary">Antibody-independent effector functions of B cells, such as antigen presentation and cytokine production, have been shown to play an important role in a variety of immune-mediated conditions such as autoimmune diseases, transplant rejection and graft-versus-host disease.  Therapeutic strategies, which interfere with B cell activation could therefore be a useful addition to the current immunosuppressive armamentarium. CD40 is one of the strongest activation stimuli for B cells. The aim of this study was to characterise the gene expression changes that occurr after B cell activation via CD40. Purified B cells isolated from PBMCs from four donors were compared to B cells which</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-54017</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-54017/samples/</item></data></biogps>
